The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Tiuvina N.A.

Kafedra psikhiatrii i meditsinskoĭ psikhologii Pervogo Moskovskogo gosudarstvennogo universiteta im. I.M. Sechenova, Moskva

Balabanova V.V.

Sechenov First Moscow State Medical University, Moscow, Russia

Voronina E.O.

Sechenov First Moscow State Medical University, Moscow, Russia

The differential diagnosis and treatment of depressive disorders in climacteric transition

Authors:

Tiuvina N.A., Balabanova V.V., Voronina E.O.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(3): 22‑27

DOI: 10.17116/jnevro20171173122-27

Read: 10158 times

Download PDF (RU)
Contact the author
Table of contents

THE DIFFERENTIAL DIAGNOSIS AND TREATMENT OF DEPRESSIVE DISORDERS IN CLIMACTERIC TRANSITION
THE DIFFERENTIAL DIAGNOSIS AND TREATMENT OF DEPRESSIVE DISORDERS IN CLIMACTERIC TRANSITION

To cite this article:

Tiuvina NA, Balabanova VV, Voronina EO. The differential diagnosis and treatment of depressive disorders in climacteric transition. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(3):22‑27. (In Russ.)
https://doi.org/10.17116/jnevro20171173122-27

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Diagnosis of pathological and adaptive bala­nce changes in Parkinson’s disease to select a reha­bilitation program. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):88-94
The state of mental health of migrant workers and citi­zens of the Russian Fede­ration: A comparative analysis as illu­strated by the Moscow region. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):95-101
Factors of depression acco­rding to acti­graphy in the fall season. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):27-32
Cognitive impairment in patients with multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):67-73
Identification of depression biomarkers: Prospects for use in clinical practice. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):51-55
Depression Anxiety Stress Scale (russian language version). S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):103-107
Inve­stigation of the rela­tionship of indi­vidual characteristics of the brain bioelectrical acti­vity with levels of mental stress, aggression, anxiety, and depression. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):108-117
Postoperative peri­tonitis: epidemiology, diagnosis, surgical treatment and prognosis. Piro­gov Russian Journal of Surgery. 2025;(6):104-111
Comparative analysis of methods for diagnosing sleep apnea. Russian Rhinology. 2025;(2):137-142
Chro­nic obstructive pulmonary disease (COPD 2024). Clinical guidelines (short version). Journal of Respiratory Medi­cine. 2025;(2):5-16
Abstract:

Objective. To study clinical symptoms of menopause depression, develop differential diagnostic criteria and consider treatment aspects. Material and methods. One hundred and fifty women, aged 41—65 years, with mental disorders developed in different periods of menopause (perimenopause, menopause and post menopause) were studied. Results and conclusion. Four types of depression were diagnosed: climacteric (n=46), psychogenic (n=35), endogenic (n=42) and involutional (n=27). Clinical characteristics of each type are presented in the aspect of correlations between psychopathological and climacteric (somatic) symptoms. Therapy of the depressions is discussed in light of literature on psychopharmacological, hormonal treatment and psychotherapy. The efficacy of antidepressants, in particular valdoxan (agomelatine), is highlighted.

Keywords:

depression
diagnosis
menopausal transition
climacteric syndrome
therapy
antidepressants

Authors:

Tiuvina N.A.

Kafedra psikhiatrii i meditsinskoĭ psikhologii Pervogo Moskovskogo gosudarstvennogo universiteta im. I.M. Sechenova, Moskva

Balabanova V.V.

Sechenov First Moscow State Medical University, Moscow, Russia

Voronina E.O.

Sechenov First Moscow State Medical University, Moscow, Russia

Close metadata

References:

  1. Serr DM, Atlas M. The Menopause: Clinical, Endocrinological and Pathophysiological Aspects. Eds. Fioretti P., Martini L., Melis G.B., Yen S.S.C. London—New York. 1982;507-515.
  2. Smetnik VP, Tkachenko NM, Glezer GA, Moskalenko NP. Klimaktericheskii sindrom. M. 1988. (In Russ.).
  3. Smetnik VP, Kulakov VI. Rukovodstvo po klimakteriyu. M.: Meditsinskoe informatsionnoe agentstvo; 2001. (In Russ.).
  4. Whitehead M, Studd J. The Menopause. Eds. Whitehead M., Studd J. Oxford. 1988;116-129.
  5. Utian WH. Psychococial and socioeconomic burden of vasomotor symptoms in menopause: A comprehencive review. Health and Qual of Life Outcomes. 2005;3:47. doi: 10.1186/1477-7525-3-47
  6. Yureneva SV, Kamenetskaya TYa. Depressive disorders in women in peri- and postmenopausal women. Zhurn ginekol. 2007;9(2):5-12. (In Russ.).
  7. Kronenberg F. Hot flashes: phenomenology, quality of life, and search for treatment options. Exp Gerontol. 1994;29:319-336. doi: 10.1016/0531-5565(94)90012-4
  8. Tyuvina NA. Psikhicheskie narusheniya u zhenshchin v period klimakteriya. M.: Kron-press; 1996. (In Russ.).
  9. Utian WH, Serr D M. Consensus on Menopause Research. Eds. van Keep P.A., Greenblatt R.B., Albeaux-Fernet M.A. Lancaster. 1976;1-4. doi: 10.1007/978-94-011-7179-3
  10. Estrogen Effects in Psychiatric Disorders. Eds. Bergemann N., Reicher-Rössler A. Springer-Verlag. 2005;291. doi: 10.1007/b12686
  11. Schindler BA. The psychiatric disorders of midlife. Med Clin North Am. 1987;71(1):71-85. doi: 10.1016/s0025-7125(16)30883-5
  12. Schindler HPG. The Controversial Climacteric. Eds. van Keep P.A., Utian W.H., Vermeulen A. Lancaster. 1981;9-18.
  13. Tyuvina NA. Features of treatment of depressive disorders in women. Zhurn psikhiatr i psikhofarmakoter. 2008;10(3):12-15. (In Russ.).
  14. Tyuvina NA, Balabanova VV. Prevention and treatment of mental disorders of menopause. Zhurn nevropatol i psikhatr im. S.S. Korsakova. 1991;9:79-82. (In Russ.).
  15. Blumenthal SJ. Women and depression. J Womens Health Gend Based Med. 1994;3:467-479. doi: 10.1089/jwh.1994.3.467
  16. Oishi A, Mochizuki Y, Otsu R, Inaba N. Pilot study of fluvoxamine treatment for climacteric symptoms in Japanese women. Bio PsychoSocial Med. 2007;1:12-16. doi: 10.1186/1751-0759-1-12
  17. Stearns V, Isaacs C, Rowland J et al. A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors. ANN ONCOL. 2000;11:17-22.
  18. Stearns V, Beebe KL, Iyengar M, Dube E. Paroxetine controlled release in the treatment of menopausal hot flashes. JAMA. 2003;289:2827-2834. doi: 10.1001/jama.289.21.2827
  19. Loprinzi CL, Sloan JA, Perez EA, Quella SK, Stella PJ, Mailliard JA, Halyard MY, Pruthi S, Novotny PJ, Rummans TA. Phase III evaluation of fluoxetine for treatment of hot flashes. J Clin Oncol. 2002;20:1578-1583.
  20. Carroll DG, Kelley KW. Use of antidepressants for management of hot flashes. Psychopharmacother. 2009;29(11):1357-1374. doi: 10.1592/phco.29.11.1357
  21. Parry BL. Optimal management of perimenopausal depression. Int J Womens Health. 2010;2:143-151. doi: 10.2147/ijwh.s7155
  22. Ware MR. Fluvoxamine: A review of the controlled trial in depression. J Clin Psychiatry. 1997;58(suppl 5):15-23.
  23. Minuzzi L, Frey BN, Soares CN. Depression During the Menopausal Transition: An Update on Epidemiology and Biological Treatments. 2012;10:1:22-27. doi: 10.1176/appi.focus.10.1.22
  24. Kennedy SH. Treating each and every depressed patient. Journal of psychopharmacology. 2008;22(suppl 7):19-23. doi: 10.1177/0269881108093270
  25. Kornstein SG, Sloan MD, Thase ME. Gender-specific differences in depression and treatment response. Psychopharmacol Bull. 2002;36(4 suppl 3):99-112.
  26. Kasper S, Corruble E, Hale A, Lemoine P, Montgomery SAF, Quera-Salva M-A. Antidepressant efficacy of agomelatine versus SSRI/SNRI results from a pooled analysis of head — to — head studies without a placebo control. International Clinical Psychopharmacology. 2013;28:12-19. doi: 10.1097/YIC.0b013e328359768e
  27. Brandon AR, Minhajuddin A, Thase ME, Jarrett RB. Impact of Reproductive Status and Age on Response of Depressed Women to Cognitive Therapy. J Womens Health (Larchmt). 2013;22(1):58-66. doi: 10.1089/jwh.2011.3427
  28. Green SM, Haber E, McCabe RE, Soares CN. Cognitive-behavioural group treatment for menopausal symptoms: a pilot study. Arch Womens Ment Health. 2013;16(4):325-332. doi: 10.1007/s00737-013-0339-x
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.